Macquarie Group LTD Cytokinetics Inc Transaction History

Macquarie Group LTD

$85.1 Billion
Q2 2024

A detailed history of Macquarie Group LTD transactions in Cytokinetics Inc stock. As of the latest transaction made, Macquarie Group LTD holds 73,599 shares of CYTK stock, worth $4.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

73,599

Previous 101,044 27.16%

Holding current value

$4.09 Million

Previous $7.08 Million 43.72%

% of portfolio

0.0%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$47.86 - $75.05 $1.31 Million - $2.06 Million	-27,445 Reduced 27.16%	73,599 $3.99 Million
Q1 2024 May 14, 2024	BUY	$63.75 - $108.06 $3.77 Million - $6.38 Million	59,060 Added 140.67%	101,044 $7.08 Million
Q4 2023 Feb 14, 2024	SELL	$26.88 - $83.49 $155,232 - $482,154	-5,775 Reduced 12.09%	41,984 $3.51 Million
Q3 2023 Nov 14, 2023	BUY	$29.46 - $36.61 $266,878 - $331,649	9,059 Added 23.41%	47,759 $1.41 Million
Q2 2023 Aug 14, 2023	BUY	$32.62 - $40.75 $74,243 - $92,747	2,276 Added 6.25%	38,700 $1.26 Million
Q1 2023 May 15, 2023	SELL	$33.36 - $45.71 $1.24 Million - $1.7 Million	-37,236 Reduced 50.55%	36,424 $1.28 Million
Q4 2022 Feb 21, 2023	SELL	$35.77 - $51.11 $1.45 Million - $2.08 Million	-40,645 Reduced 35.56%	73,660 $3.38 Million
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $1.34 Million - $1.9 Million	34,847 Added 43.86%	114,305 $5.58 Million
Q2 2022 Aug 15, 2022	BUY	$33.93 - $48.92 $955,333 - $1.38 Million	28,156 Added 54.88%	79,458 $3.12 Million
Q1 2022 May 16, 2022	BUY	$29.74 - $46.0 $168,179 - $260,130	5,655 Added 12.39%	51,302 $1.89 Million
Q4 2021 Feb 11, 2022	SELL	$34.35 - $46.38 $526,104 - $710,356	-15,316 Reduced 25.12%	45,647 $2.08 Million
Q3 2021 Nov 12, 2021	SELL	$18.54 - $35.74 $252,811 - $487,350	-13,636 Reduced 18.28%	60,963 $2.18 Million
Q2 2021 Aug 13, 2021	SELL	$19.79 - $26.99 $3,166 - $4,318	-160 Reduced 0.21%	74,599 $1.48 Million
Q1 2021 May 14, 2021	BUY	$18.57 - $25.68 $82,989 - $114,763	4,469 Added 6.36%	74,759 $1.74 Million
Q4 2020 Feb 16, 2021	BUY	$15.26 - $28.61 $1.04 Million - $1.96 Million	68,333 Added 3491.72%	70,290 $1.46 Million
Q2 2020 Aug 11, 2020	BUY	$11.15 - $24.64 $21,820 - $48,220	1,957 New	1,957 $46,000
Q1 2018 May 11, 2018	SELL	$7.2 - $10.05 $6,480 - $9,045	-900 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$7.25 - $15.65 $6,525 - $14,085	900	900 $7,000

Others Institutions Holding CYTK

# of Institutions

406

Shares Held

126M

Call Options Held

3.29M

Put Options Held

2.01M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $5.23B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Cytokinetics Inc Transaction History